SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041726
Filing Date
2019-11-07
Accepted
2019-11-07 16:07:03
Documents
74
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q3-2019_093019 ctmx-10q_20190930.htm   iXBRL 10-Q 2927676
2 EX-10.1 ctmx-ex101_559.htm EX-10.1 110205
3 EX-10.2 ctmx-ex102_564.htm EX-10.2 57625
4 EX-10.3 ctmx-ex103_563.htm EX-10.3 55469
5 EX-10.4 ctmx-ex104_562.htm EX-10.4 63763
6 EX-10.5 ctmx-ex105_561.htm EX-10.5 26729
7 EX-10.6 ctmx-ex106_560.htm EX-10.6 92869
8 EX-31.1 ctmx-ex311_8.htm EX-31.1 19479
9 EX-31.2 ctmx-ex312_7.htm EX-31.2 19534
10 EX-32.1 ctmx-ex321_10.htm EX-32.1 10495
11 EX-32.2 ctmx-ex322_6.htm EX-32.2 10939
12 GRAPHIC gzqnrktxoexo000001.jpg GRAPHIC 5104
13 GRAPHIC g5qijpkapw2f000001.jpg GRAPHIC 3697
14 GRAPHIC gxultspa5oia000001.jpg GRAPHIC 3697
15 GRAPHIC gfgjrdt5f1n0000001.jpg GRAPHIC 3697
16 GRAPHIC gfgjrdt5f1n0000002.jpg GRAPHIC 9284
  Complete submission text file 0001564590-19-041726.txt   9472202

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA ctmx-20190930.xsd EX-101.SCH 62872
18 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctmx-20190930_cal.xml EX-101.CAL 47827
19 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctmx-20190930_def.xml EX-101.DEF 226256
20 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctmx-20190930_lab.xml EX-101.LAB 418140
21 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctmx-20190930_pre.xml EX-101.PRE 355102
65 EXTRACTED XBRL INSTANCE DOCUMENT ctmx-10q_20190930_htm.xml XML 1558510
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 191200332
SIC: 2834 Pharmaceutical Preparations